JP2002534388A5 - - Google Patents

Download PDF

Info

Publication number
JP2002534388A5
JP2002534388A5 JP2000592004A JP2000592004A JP2002534388A5 JP 2002534388 A5 JP2002534388 A5 JP 2002534388A5 JP 2000592004 A JP2000592004 A JP 2000592004A JP 2000592004 A JP2000592004 A JP 2000592004A JP 2002534388 A5 JP2002534388 A5 JP 2002534388A5
Authority
JP
Japan
Prior art keywords
inhibitor
plates
nitroaniline
triplicate
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000592004A
Other languages
English (en)
Other versions
JP3822439B2 (ja
JP2002534388A (ja
Filing date
Publication date
Priority claimed from GBGB9900413.7A external-priority patent/GB9900413D0/en
Priority claimed from GBGB9917294.2A external-priority patent/GB9917294D0/en
Application filed filed Critical
Priority claimed from PCT/GB2000/000032 external-priority patent/WO2000040247A1/en
Publication of JP2002534388A publication Critical patent/JP2002534388A/ja
Publication of JP2002534388A5 publication Critical patent/JP2002534388A5/ja
Application granted granted Critical
Publication of JP3822439B2 publication Critical patent/JP3822439B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

アッセイは９６ウエルＥＬＩＳＡプレート中、３重測定で準備された。１０μｌの２μｇ／ｍｌのトリプシン、２６μｌの希釈阻害剤、及び１９０μｌの基質が連続して加えられた。次にプレートをＢｉｏＲａｏｄ Ｂｅｎｃｈｍａｒｋマイクロプレートリーダー中、３７℃にてインキュベーションした。阻害剤なしの酵素に対するｐ−ニトロアニリンの放出率を、４０５ｎｍにおいて１０分間測定した。
アッセイは９６ウエルＥＬＩＳＡプレート中、３重測定で準備された。１０μｌの５０μｇ／ｍｌのキモトリプシン、５０μｌの希釈阻害剤、及び１９０μｌの基質が連続して加えられた。次にプレートをＢｉｏＲａｏｄ Ｂｅｎｃｈｍａｒｋマイクロプレートリーダー中、３７℃にてインキュベーションした。阻害剤なしの酵素に対するｐ−ニトロアニリンの放出率を、４０５ｎｍにおいて１０分間測定した。
JP2000592004A 1999-01-08 2000-01-06 肥満治療用２−オキシ−４ｈ−３，１−ベンゾオキサジン−４−オン Expired - Fee Related JP3822439B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9900413.7A GB9900413D0 (en) 1999-01-08 1999-01-08 Inhibitors
GB9900413.7 1999-01-08
GB9917294.2 1999-07-22
GBGB9917294.2A GB9917294D0 (en) 1999-07-22 1999-07-22 Inhibitors
PCT/GB2000/000032 WO2000040247A1 (en) 1999-01-08 2000-01-06 2-oxy-benzoxazinone derivatives for the treatment of obesity

Publications (3)

Publication Number Publication Date
JP2002534388A JP2002534388A (ja) 2002-10-15
JP2002534388A5 true JP2002534388A5 (ja) 2006-03-09
JP3822439B2 JP3822439B2 (ja) 2006-09-20

Family

ID=26314965

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000592004A Expired - Fee Related JP3822439B2 (ja) 1999-01-08 2000-01-06 肥満治療用２−オキシ−４ｈ−３，１−ベンゾオキサジン−４−オン

Country Status (24)

Country Link
US (4) US6624161B2 (ja)
EP (1) EP1143977B3 (ja)
JP (1) JP3822439B2 (ja)
KR (1) KR100678998B1 (ja)
CN (2) CN1315813C (ja)
AR (1) AR022204A1 (ja)
AT (1) ATE293447T1 (ja)
AU (1) AU765147C (ja)
CA (1) CA2359819C (ja)
CH (1) CH1143977H1 (ja)
DE (1) DE60019555C5 (ja)
DK (1) DK1143977T3 (ja)
ES (1) ES2240052T7 (ja)
HK (2) HK1047588B (ja)
HU (1) HUP0105003A3 (ja)
MX (1) MXPA01006921A (ja)
MY (1) MY122578A (ja)
NO (1) NO333922B1 (ja)
NZ (1) NZ512740A (ja)
PL (1) PL207383B1 (ja)
PT (1) PT1143977E (ja)
RU (1) RU2245331C2 (ja)
SI (1) SI1143977T1 (ja)
WO (1) WO2000040247A1 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022204A1 (es) * 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
GB0001572D0 (en) 2000-01-24 2000-03-15 Alizyme Therapeutics Ltd Inhibitors
US6504028B2 (en) * 2000-07-11 2003-01-07 The Procter & Gamble Co. Process for preparing benzoxazin-4-one polymer conjugates
EP1425029A4 (en) 2001-08-10 2006-06-07 Palatin Technologies Inc PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES
MXPA04001922A (es) * 2001-08-30 2005-03-07 Alizyme Therapeutics Ltd Tieno-(1,3)-oxazin-4-onas con actividad inhibidora de lipasa.
AU2002366810B2 (en) * 2001-12-20 2009-06-11 Osi Pharmaceuticals, Inc. Pancreatic lipase inhibitor compounds, their synthesis and use
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
AU2004246895A1 (en) * 2003-06-12 2004-12-23 Biomas Ltd. Methods of treating obesity and related disorders using tellurium and selenium compounds
GB0319124D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
US20050239859A2 (en) * 2003-09-03 2005-10-27 Solvay Pharmaceuticals Gmbh Novel medical uses of 4,5-dihydro-1h-pyrazole derivatives having cb1- antagonistic activity
US20050124660A1 (en) * 2003-10-27 2005-06-09 Jochen Antel Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds
US20050143441A1 (en) * 2003-10-27 2005-06-30 Jochen Antel Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
WO2006045799A2 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
WO2006116773A2 (en) * 2005-04-28 2006-11-02 The Regents Of The University Of California Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders
US20090208584A1 (en) * 2005-06-09 2009-08-20 Tomohiro Yoshinari Solid preparation
JP2010254623A (ja) 2009-04-24 2010-11-11 Takeda Chem Ind Ltd ベンゾオキサジノン化合物の結晶
ES2662710T3 (es) 2010-05-24 2018-04-09 Swedish Oat Fiber Ab Dispersión acuosa que comprende galactolípidos y método de producción de la misma
AU2012101841A4 (en) * 2011-12-23 2013-01-17 Norgine Bv Compositions comprising cetilistat
WO2013092786A1 (en) 2011-12-23 2013-06-27 Norgine B.V. Compositions comprising cetilistat
DE202012104963U1 (de) 2012-12-19 2013-01-14 Norgine B.V. Cetilistat aufweisende Zusammensetzungen
CN103936687B (zh) * 2014-03-24 2016-03-30 重庆东得医药科技有限公司 一种制备西替利司他的方法
CN104374836A (zh) * 2014-09-19 2015-02-25 安徽安科生物工程（集团）股份有限公司 西替利司他及有关杂质的hplc测定方法
CN105622538B (zh) * 2014-10-27 2019-02-01 中国医学科学院药物研究所 一锅法高收率制备新利司他
CN104341370B (zh) * 2014-11-11 2017-02-22 山东创新药物研发有限公司 一种西替利司他的制备方法
CN105566164A (zh) * 2016-01-06 2016-05-11 北京修正创新药物研究院有限公司 一种新利司他杂质的制备方法
CN105669585A (zh) * 2016-01-06 2016-06-15 北京修正创新药物研究院有限公司 一种新利司他的制备方法
WO2018011676A1 (en) * 2016-07-11 2018-01-18 Symed Labs Limited Novel processes for the preparation of 2-oxy-benzoxazinone derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246996C (ja)
US4657893A (en) 1984-05-09 1987-04-14 Syntex (U.S.A.) Inc. 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
US4745116A (en) 1985-06-25 1988-05-17 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
DD246996A1 (de) * 1986-02-26 1987-06-24 Univ Leipzig Verfahren zur herstellung von gegebenenfalls substituierten 2-alkoxy- bzw. 2-aroxy-3,1-benzoxazin-4-onen
CA1309556C (en) * 1987-06-09 1992-10-27 Masayuki Kokubo 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases
US5652237A (en) 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
US5985872A (en) * 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections
US5776756A (en) * 1995-08-31 1998-07-07 Toyo Hakko Co., Ltd. Fermentation compositions having superoxide dismutating activity and an antihypertensive agent for treatment of constipation each having the superoxide dismutating activity
US6207371B1 (en) * 1996-10-04 2001-03-27 Lexicon Genetics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US6139833A (en) * 1997-08-08 2000-10-31 Lexicon Genetics Incorporated Targeted gene discovery
US6136566A (en) * 1996-10-04 2000-10-24 Lexicon Graphics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US6130214A (en) * 1997-10-27 2000-10-10 Dr. Reddy's Research Foundation Benzothiazin and benzoxazin derivatives; their preparation and uses
US6080576A (en) * 1998-03-27 2000-06-27 Lexicon Genetics Incorporated Vectors for gene trapping and gene activation
AR022204A1 (es) 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.

Similar Documents

Publication Publication Date Title
JP2002534388A5 (ja)
WO2000076971A3 (en) Serine protease inhibitors
WO2000077027A3 (en) Serine protease inhibitors
BR0111451A (pt) Inibidores de serina protease
IS2714B (is) Uppsöfnun í frumu á phosphomate hliðstæðum á HIV próteasa hindrandi efnasamböndum
FR2840067B1 (fr) Capteur de pression a semiconducteur du type mambrane et tranche de semiconducteur utilisee pour sa fabrication
BR9713871A (pt) Tablete detergente revestido
GEP20104878B (en) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
AU2001247782A1 (en) 18221, dual specificity phosphatase and uses thereof
DE60117966D1 (de) Rotierendes ausbruchsverhütungsventil für hohen druck
AU2001244719A1 (en) Novel fluoropolymer having acid-reactive group and chemical amplification type photoresist composition containing the same
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
DE60140766D1 (de) Drucksteuerung in der Umgebung eines Wafers
CA2360881A1 (en) A method for creating a patterned concrete surface
WO2001056553A3 (en) Pharmaceutically active aromatic guanylhydrazones
DE60140929D1 (de) Immunoassay für HIV-Protease-Hemstoffe
USD509604S1 (en) Hex tile
NO20013675L (no) 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer
WO2003093786A3 (en) Short enzyme donor fragment
TW200616933A (en) Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors
DE50008361D1 (de) Plättchenförmige presskörper
BR0108579B1 (pt) método de fabricação de um prato de válvula de compressor, prato de válvula obtido, unidade de válvula compreendendo o prato de válvula e compressor compreendendo dito prato de válvula.
DK1054158T3 (da) Omlöbsventil til höjtryksvaskemaskiner
FR2788762B1 (fr) Liant du type clinker, utilisation et procede de fabrication d'un tel liant
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril